BioSpace News Archive

FzioMed is pleased to announce the enrollment of patient number one in the supportive study of Oxiplex® in patients undergoing lumbar surgery for disc herniation

Agency responds to citizen petition, announces agreements with universities, updates bulks categories and schedules advisory committee meeting

Teva’s Copaxone remains the brand share leader among new start patients year-over-year, although neurologists are beginning to write prescriptions for Mylan’s generic glatiramer acetate and Sandoz’s Glatopa independent of direct payer influence, according to a recently published independent audit from Spherix Global Insights

Rowley Law PLLC is investigating potential claims against LifePoint Health, Inc. (NASDAQ: LPNT) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Apollo Global Management.

Cipher Pharmaceuticals Inc. announced the details of its Q2 2018 financial results conference call on Friday, August 10, 2018.

Fletcher Spaght Inc. (FSI) is proudly celebrating 35 years as a leader in growth-focused strategy consulting centered on innovation and accelerating organic and inorganic growth within the global healthcare and technology industries.

And expands production capabilities through acquisition of TailorMed Ltd.

A new California Workers’ Compensation Institute (CWCI) analysis offers a preliminary look at Utilization Review (UR) and Independent Medical Review (IMR) outcomes involving pharmaceutical requests for California injured workers since the state implemented a workers’ comp formulary in January of this year.

Series C funding led by Draper Esprit

On Friday, key US indices were bearish as the NASDAQ Composite finished the trading session down 0.07%; the Dow Jones Industrial Average edged 0.03% lower; and the S&P 500 was down 0.09%.